Image Place holder

Silvia Bunting, MD, MSc

Specialty: Pathology
Program: Pathology

Call 1-888-MOFFITT

Call 1-888-MOFFITT


Cancer Focus: Hodgkin Lymphoma , Leukemia , MDS, Multiple Myeloma-Plasma Cell Tumor , Myelodysplastic Syndromes (MDS) , Non-Hodgkin Lymphoma

Dr. Silvia Bunting is an Associate Member in the Moffitt Cancer Center Department of Hematopathology and Laboratory Medicine. Dr. Bunting serves as the Director of Flow Cytometry. Dr. Bunting earned her medical degree from Sun Yat-Sen University of Medical Sciences, Guangzhou, China. She completed a Pathology Residency in the Department of Pathology, University of Maryland Medical Center, Baltimore, where she also served as Chief Resident. Dr. Bunting completed a Surgical/Cytopathology Fellowship at Case Western Reserve University Hospitals of Cleveland, in Ohio, and a Hematopathology Fellowship at Cleveland Clinic Foundation Ohio. After completing her fellowships, Dr. Bunting was a Clinical Associate in the Department of Clinical Pathology at Cleveland Clinic; then Associate Pathologist/Hematopathologist at Summit Health Pathology Associates and most recently a Hematopathologist in the Department of Pathology, Children’s Healthcare of Atlanta, and Adjunct Assistant Professor in the Department of Pathology, Emory University School of Medicine, Atlanta, Georgia. Dr. Bunting’s clinical interests include optimizing the role of flow cytometry as an ancillary diagnostic tool in hematologic neoplasms such as leukemia and myelodysplastic syndrome, and diagnosis of hematologic neoplasms in adolescents and young adults. Her research interest includes using state-of-the-art flow cytometry technology to identify functional targets and molecular mechanisms of hematologic malignancies. 

Education & Training

Board Certification:

  • Pathology-Anatomic


  • Princess Margaret Hospital, Ontario Cancer Institute -
  • National Cancer Institute -
  • Case Western Reserve University Hospitals of Cleveland - Surgical/Cytopathology
  • Cleveland Clinic Foundation - Hematopathology


  • University of Maryland Medical Center Baltimore - Pathology

Medical School:

  • Sun Yat-Sen University of Medical Sciences(BM, - BM)
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Eason AC, Bunting ST, Peterson JF, Saxe D, Sabnis HS. Acute Myeloid Leukemia in an Infant with t(8;19)(p11.2;q13) Translocation: Case Report and a Review of the Literature. Case Rep Hematol. 2019 Sep.2019:4198415. Pubmedid: 31583141. Pmcid: PMC6754882.
  • Wang Z, Vaughan TY, Zhu W, Chen Y, Fu G, Medrzycki M, Nishio H, Bunting ST, Hankey-Giblin PA, Nusrat A, Parkos CA, Wang D, Wen R, Bunting KD. Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation. Front Immunol. 2019 Mar.10:486. Pubmedid: 30936879. Pmcid: PMC6431666.
  • Chonat S, McLemore ML, Bunting ST, Nortman S, Zhang K, Kalfa TA. Congenital dyserythropoietic anaemia type I diagnosed in a young adult with a history of splenectomy in childhood for presumed haemolytic anaemia. Brit J Haematol. 2018 Jul.182(1):10. Pubmedid: 29676459.
  • Bhatia AK, Yabrodi M, Carroll M, Bunting S, Kanter K, Maher KO, Deshpande SR. Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devices. World J Cardiol. 2017 Sep.9(9):749-756. Pubmedid: 29081908. Pmcid: PMC5633539.
  • Bunting CT, Senior T, Susson Y, Rivera A, Saxe D, Bunting ST. Utility of Fluorescence In Situ Hybridization Panel for Myelodysplastic Syndrome in Evaluation of Cytopenia in a Pediatric Hospital: A 5-Year Retrospective Review and Utilization Management. Lab Med. 2017 Aug;48(3):266-270. Pubmedid: 28934515.
  • Mitchell SG, Bunting ST, Saxe D, Olson T, Keller FG. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia. Pediatr Blood Cancer. 2017 Apr;64(4). Pubmedid: 27781377.
  • Myers DR, Qiu Y, Fay ME, Tennenbaum M, Chester D, Cuadrado J, Sakurai Y, Baek J, Tran R, Ciciliano JC, Ahn B, Mannino RG, Bunting ST, Bennett C, Briones M, Fernandez-Nieves A, Smith ML, Brown AC, Sulchek T, Lam WA. Single-platelet nanomechanics measured by high-throughput cytometry. Nat Mater. 2017 02;16(2):230-235. Pubmedid: 27723740. Pmcid: PMC5266633.
  • Raikar SS, Scarborough JD, Sabnis H, Bergsagel J, Wu D, Cooper TM, Keller FG, Wood BL, Bunting ST. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia. Pediatr Blood Cancer. 2016 Sep;63(9):1667-1670. Pubmedid: 27145535.
  • Dong L, Yu WM, Zheng H, Loh ML, Bunting ST, Pauly M, Huang G, Zhou M, Broxmeyer HE, Scadden DT, Qu CK. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 2016 Nov;539(7628):304-308. Pubmedid: 27783593. Pmcid: PMC5317374.
  • Guillory T, Li S, Bergsagel DJ, Weinzierl E, Bunting ST. Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall. Lab Med. 2016 May;47(2):163-170. Pubmedid: 27069035. Pmcid: PMC4832592.
  • Wang Z, Medrzycki M, Bunting ST, Bunting KD. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis. Oncotarget. 2015 Oct;6(30):28961-28972. Pubmedid: 26338970. Pmcid: PMC4745704.
  • Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget. 2015 Aug;6(24):20697-20710. Pubmedid: 26079538. Pmcid: PMC4653036.
  • Tyburski EA, Gillespie SE, Stoy WA, Mannino RG, Weiss AJ, Siu AF, Bulloch RH, Thota K, Cardenas A, Session W, Khoury HJ, O'Connor S, Bunting ST, Boudreaux J, Forest CR, Gaddh M, Leong T, Lyon LA, Lam WA. Disposable platform provides visual and color-based point-of-care anemia self-testing. J Clin Invest. 2014 Oct;124(10):4387-4394. Pubmedid: 25157824. Pmcid: PMC4191020.
  • Sabnis H, Bradley HL, Bunting ST, Cooper TM, Bunting KD. Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia. J Transl Med. 2014 Jun;12:166. Pubmedid: 24923301. Pmcid: PMC4080754.
  • Bunting ST, Lew G. “Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia. Blood. 2014 Apr;123(16):2448. Pubmedid: 24860885.
  • Doshi BS, Abramowsky C, Briones M, Bunting ST. Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature. Am J Blood Res. 2014;4(1):41-45. Pubmedid: 25232504. Pmcid: PMC4165116.
  • Liang X, Russell SR, Estelle S, Jones LH, Cho S, Kahn ML, Berndt MC, Bunting ST, Ware J, Li R. Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost. 2013 Dec;11(12):2155-2162. Pubmedid: 24119228. Pmcid: PMC3947459.
  • Chen L, Richendollar B, Bunting S, Campbell S, Zhou M. Lymphomas and lymphoproliferative disorders clinically presenting as renal carcinoma: a clinicopathological study of 14 cases. Pathology. 2013 Dec;45(7):657-663. Pubmedid: 24247623.
  • Stowell SR, Henry KL, Smith NH, Hudson KE, Halverson GR, Park JC, Bennett AM, Girard-Pierce KR, Arthur CM, Bunting ST, Zimring JC, Hendrickson JE. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood. 2013 Aug;122(8):1494-1504. Pubmedid: 23801629. Pmcid: PMC3750342.
  • Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, Ryan JJ, Tse W, Moriggl R, Bunting KD. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood. 2010 Feb;115(7):1416-1424. Pubmedid: 20008792. Pmcid: PMC2826763.
  • Li G, Miskimen KL, Wang Z, Xie XY, Tse W, Gouilleux F, Moriggl R, Bunting KD. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Leukemia. 2010 Aug;24(8):1397-1405. Pubmedid: 20535152. Pmcid: PMC2921023.
  • Amado A, McDonnell JK, Somani N, Bunting ST, Winfield HL. Cutaneous gamma-delta T-cell lymphoma. Leuk Lymphoma. 2008 Oct;49(10):2003-2005. Pubmedid: 18949623.
  • Xie X, Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol. 2008 Jun;21(6):653-659. Pubmedid: 18264083.
  • Bunting KD, Xie XY, Warshawsky I, Hsi ED. Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Blood. 2007 Oct;110(7):2775-2776. Pubmedid: 17881646. Pmcid: PMC1988940.
  • Xie XY, Carter N, Darwin PE, Drachenberg CB. Gastrointestinal stromal tumors: update. Arkh Patol. 2004 Mar;66(2):36-40. Pubmedid: 15154382.
  • Xie XY, Strauch E, Sun CC. Choledochal cysts and multilocular cysts of the pancreas. Hum Pathol. 2003 Jan;34(1):99-101. Pubmedid: 12605374.
  • Benitez RM, Siegel E, Xie XY. A 50-year-old man with chest pain. Am J Med Sci. 2003 Feb;325(2):70-74. Pubmedid: 12589231.
  • Kingma DW, Imus P, Xie XY, Jasper G, Sorbara L, Stewart C, Stetler-Stevenson M. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms. Cytometry. 2002 Oct;50(5):243-248. Pubmedid: 12360573.
  • Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001 Aug;98(4):979-987. Pubmedid: 11493442.
  • Xie XY, Sorbara L, Kreitman RJ, Fukushima PI, Kingma DW, Stetler-Stevenson M. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia. Leuk Lymphoma. 2000 Mar;37(1-2):97-104. Pubmedid: 10721773.
  • Xie XY, Filie AC, Jasper GA, Fukushima PI, Stetler-Stevenson M. Diagnosis of unexpected acute myeloid leukemia and chronic lymphocytic leukemia: a case report demonstrating the perils of restricted panels in flow cytometric immunophenotyping. Cytometry. 2000 Apr;42(2):114-117. Pubmedid: 10797449.
  • Hedley DW, Xie SX, Minden MD, Choi CH, Chen H, Ling V. A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia. 1997 Jan;11(1):48-53. Pubmedid: 9001418.
  • Xie XY, Robb D, Chow S, Hedley DW. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia. 1995 Nov;9(11):1882-1887. Pubmedid: 7475279.
  • Xie XY, Archer MC. Metabolism of N-nitrosomethylbenzylamine by microsomes from perivenous and periportal hepatocytes. Cancer Lett. 1994 Jun;81(1):27-31. Pubmedid: 7912647.